$ST George Mining Ltd (SGQ.AU)$ hopefully something big is happening here 🤞

$ST George Mining Ltd (SGQ.AU)$ Prepared 200,000, adding 8,000 every 0.03 interval.

$ST George Mining Ltd (SGQ.AU)$ The hidden dragon plays in the water, profound and inscrutable.

$ST George Mining Ltd (SGQ.AU)$ If the main force can see this, please push for a 15% increase. My grandfather 👴🏻 is seriously ill, and I don't have enough money despite my efforts to gather funds. I still fall short and can only take a chance here. If it works, I will have done my best…

$GCM Corp Ltd (GCM.AU)$ lets go! make a move do something

$Botanix Pharmaceuticals Ltd (BOT.AU)$专利期还有很久“ In closing, we have a greatly experienced executive team, a highly productive expanded sales
force, and Sofdra, the first and only new chemical entity FDA-approved to treat primary axillary
hyperhidrosis in adults and children 9 years of age and older. Sofdra has patent protection to
2040, which provides lengthy exclusivity.”

$Botanix Pharmaceuticals Ltd (BOT.AU)$
Copia is a boutique fund management company in Australia that specializes in small- and mid-cap stocks. Its significant holdings or increased positions in a particular stock are typically viewed by the market as a positive signal.
The company added 20.6 million shares against the market trend from September to November, increasing its stake from 6.23% to 7.28%.
Path of accumulation: Purchases were made continuously from AUD 0.163 down to AUD 0.129.
The most recent block purchase occurred at the end of October at a price of CNY 0.151, followed by additional purchases near CNY 0.129.
With the current share price in the range of CNY 0.12 to CNY 0.13, Copia’s firm increase in holdings at a low level indicates optimism about the commercial prospects of the company's FDA-approved product, Sofdra.
This stock is heavily held by a renowned Australian fund management company and is worth attention. For reference only; investment requires caution.

$Botanix Pharmaceuticals Ltd (BOT.AU)$ Let’s break down the most recent announcement in simple terms:
### What the Announcement Means
Botanix Pharmaceuticals got permission (a "waiver") from the ASX (Australian stock exchange) to ask shareholders at their upcoming meeting to approve issuing some extra shares and warrants (special rights to buy shares later) as part of a $30 million loan deal with Kreos Capital. These shares and warrants would help them manage the loan without using up their usua...

$Novonix (NVX.AU)$ After watching this YouTuber's video, I feel hopeful about the future.https://youtu.be/qrodxdZQ4A4?si=1TUCoG7mlsG1KrwW